Veterinary Injectable Devices Market

By Product Type;

Syringes, Needles, Needle Free Injection System, and Others

By Usability;

Disposable and Re-Usable

By Material Type;

Plastic, Glass, and Metals

By End User ;

Veterinary Hospitals, Veterinary Clinics, and Animal Research Institutes

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn136716650 Published Date: August, 2025
Download Free Sample NowDownload Free Sample Now

Veterinary Injectable Devices Market Overview

Veterinary Injectable Devices Market (USD Million)

Veterinary Injectable Devices Market was valued at USD 898.96 million in the year 2024. The size of this market is expected to increase to USD 1,243.99 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.8%.


Veterinary Injectable Devices Market

*Market size in USD million

CAGR 4.8 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.8 %
Market Size (2024)USD 898.96 Million
Market Size (2031)USD 1,243.99 Million
Market ConcentrationHigh
Report Pages384
898.96
2024
1,243.99
2031

Major Players

  • Ceva Santé Animale
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • IDEXX Laboratories, Inc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Veterinary Injectable Devices Market

Fragmented - Highly competitive market without dominant players


The Veterinary Injectable Devices Market is rapidly evolving as veterinary clinics and livestock operations embrace advanced injection systems designed for precise, consistent drug delivery. With nearly 60% of practices incorporating modern, automated injectors for vaccines, antibiotics, and other therapies, the market is witnessing robust growth. This surge is powered by innovation in device miniaturization, user-friendly interfaces, and enhanced safety features. These shifts offer significant opportunities for manufacturers to refine product reliability and standardize treatment protocols, ultimately driving extensive market expansion.

Precision Engineering Boosting Device Accuracy
Recent technological advancements in injectable devices include smart dosing algorithms, needle‑free injection options, and automated calibration systems. Approximately 65% of new devices feature real‑time monitoring and adjustable dose control to improve injection precision and reduce medication errors. These enhancements elevate clinical outcomes and inspire confidence among practitioners, leading to broad market expansion in both routine and complex treatment scenarios.

Strategic Deployment Accelerating Adoption
Manufacturers are implementing smart strategies such as bundled treatment kits, training programs for veterinary professionals, and comprehensive service agreements. These initiatives have resulted in about 70% of large animal hospitals and 65% of small clinics now using branded injectable device systems. This deliberate rollout enhances clinician trust and facilitates smoother integration into diverse practice settings, supporting ongoing market expansion.

Smart Technologies Shaping Future Innovation
The future outlook of the market is defined by innovation in connected injectable devices featuring wireless data transfer, real‑time analytics, and cloud‑based management. Over 75% of next‑generation systems under development are expected to offer AI‑driven dosing adjustments and smart maintenance alerts. These technological advancements are anticipated to drive prolonged growth and further market expansion in the veterinary injectable devices segment.

In this report, the Veterinary Injectable Devices Market has been segmented by Product Type, Usability, Material Type, End User and Geography.

Veterinary Injectable Devices Market, Segmentation by Product Type

The Veterinary Injectable Devices Market has been segmented by Product Type into Syringes, Needles, Needle Free Injection System and Others.

Syringes
Syringes currently lead the veterinary injectable devices market with approximately 29–38% share. Their precision in dosing, affordability, and versatility across species make them indispensable in veterinary practices. With pet ownership on the rise and an expanding network of veterinary clinics and hospitals, syringes remain the backbone of animal health delivery systems.

Needles
Needles whether used solo or paired with syringes—represent a primary revenue source in the injectable devices market. These tools are integral to vaccinations, diagnostics, and therapeutic use in animals. An increasing incidence of chronic conditions and enhanced veterinary diagnostics are key drivers pushing demand for reliable needle-based solutions.

Needle Free Injection System
Needle‑free injection systems are capturing attention due to their needleless approach, which significantly reduces injury risk and improves user comfort. Though they still represent a smaller portion of the market (estimated in the low to mid‑teens percent range), their high CAGR (~15–17%) is propelling rapid expansion. Jet and gas‑powered injectors are particularly favored in livestock vaccine campaigns and self‑administration settings.

Others
Auto‑injectors, remote dosing devices, micro‑needle patches, and other emerging formats populate this segment. Though still a smaller niche, the category is evolving quickly, thanks to cutting‑edge advancements like real‑time dose monitoring and AI‑driven adjustment features. Around 65% of new veterinary delivery devices now integrate such smart technology, hinting at strong future growth.

Veterinary Injectable Devices Market, Segmentation by Usability

The Veterinary Injectable Devices Market has been segmented by Disposable and Re-Usable.

Disposable
Disposable usability dominates the veterinary injectable devices market with over 60% share in 2024. These single-use plastic injectables deliver unmatched hygiene, convenience, and cost-efficiency, minimizing infection risk and simplifying administration in both clinics and livestock settings.

Re‑Usable
While comprising roughly 40% of the market, the re‑usable segment is rapidly growing in veterinary care. These sterilizable devices offer long-term savings, feature-rich usability like smart dosing sensors, and align with sustainability goals—making them increasingly popular in high-volume and precision dosage scenarios.

Veterinary Injectable Devices Market, Segmentation by Material Type

The Veterinary Injectable Devices Market has been segmented by Material Type into Plastic, Glass and Metals.

Plastic
Plastic dominates the veterinary injectable devices market, holding approximately 45% share in 2023. These lightweight and cost-effective plastic injectables are ideal for single-use applications across veterinary clinics, mobile units, and large-scale vaccination efforts.

Glass
Glass materials account for around 35% of the market in 2023. With superior sterility, chemical stability, and precision dosing, glass prefilled syringes and vials are preferred for administering sensitive biologics and specialized therapeutic formulations.

Metals
Metal-based devices make up about 20% of the market in 2023. These durable, reusable stainless steel systems—including auto-injectors and high-volume injectors—are widely used in livestock operations and veterinary hospitals, offering longevity and cost-efficiency over repeated use.

Veterinary Injectable Devices Market, Segmentation by End User

The Veterinary Injectable Devices Market has been segmented by End User into Veterinary Hospitals, Veterinary Clinics and Animal Research Institutes.

Veterinary Hospitals
With approximately 35% of total injectable device demand, veterinary hospitals are pivotal end users. These facilities manage advanced treatment workflows—including surgeries, critical care, and complex drug protocols—and rely heavily on branded auto‑injectors and safety syringes. With more than 60% of hospitals adopting advanced devices, precision and speed are key priorities.

Veterinary Clinics
Veterinary clinics capture over 40% of market share, dominating small animal care. They deliver vaccines, manage chronic conditions, and conduct diagnostics. Injectable devices are utilized in more than 65% of treatments here, thanks to the appeal of hygienic, cheap, and easy‑to‑use disposable syringes.

Animal Research Institutes
Contributing about 10% of the injectable devices market, animal research institutes demand precision‑controlled injectables for experimental studies and trials. With over 70% of labs using high‑accuracy injectors and more than 50% choosing multi‑use adaptable systems, reproducibility and precision are paramount.

Veterinary Injectable Devices Market, Segmentation by Geography

In this report, the Veterinary Injectable Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Regions and Countries Analyzed in this Report

Legend
North America
Rest of North America
Europe
Rest of Europe
Asia Pacific
Rest of Asia Pacific
Middle East and Africa
Rest of Middle East and Africa
Latin America
Rest of Latin America
Rest of the World

Veterinary Injectable Devices Market Share (%), by Geographical Region

North America
North America dominates this sector with nearly 35–40% market share, propelled by strong veterinary infrastructure, high pet ownership levels, and robust investment in animal health services.

Europe
Europe represents around 30% of global veterinary injectable device revenue, supported by stringent quality regulations, advanced veterinary care systems, and growing emphasis on preventive animal healthcare.

Asia Pacific
Capturing approximately 20–26% of the market, the Asia Pacific region benefits from booming livestock sectors, increasing companion animal populations, and expansion of veterinary infrastructure.

Middle East & Africa
Together holding roughly 5% of the market, the Middle East and Africa regions are growing through strategic investments in livestock health initiatives, veterinary protocols, and emerging public health programs.

Latin America
Latin America accounts for about 5% of global share, with growth driven by heightened awareness of animal welfare and gradual enhancement of veterinary service networks.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Usability
    3. Market Snapshot, By Material Type
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Veterinary Injectable Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of animal diseases
        2. Growing demand for animal healthcare services
        3. Rising adoption of preventive veterinary medicine practices
        4. Technological advancements in injectable device manufacturing
        5. Growing global population of companion animals and livestock
      2. Restraints
        1. Stringent regulatory requirements for veterinary medical devices
        2. High cost associated with advanced injectable devices
        3. Limited access to veterinary healthcare in rural and remote areas
        4. Concerns regarding needlestick injuries and needle disposal
      3. Opportunities
        1. Expansion of veterinary healthcare infrastructure in emerging markets
        2. Development of novel injectable devices for specialized veterinary applications
        3. Increasing focus on animal welfare and preventive healthcare measures
        4. Collaborations and partnerships between veterinary device manufacturers and animal health organizations
        5. Adoption of digital health technologies for remote monitoring and management of animal health
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Veterinary Injectable Devices Market, By Product Type, 2021-2031 (USD Million)
      1. Syringes
      2. Needles
      3. Needle Free Injection System
      4. Others

    2. Veterinary Injectable Devices Market, By Usability, 2021-2031 (USD Million)

      1. Disposable

      2. Re-Usable

    3. Veterinary Injectable Devices Market, By Material Type, 2021-2031 (USD Million)
      1. Plastic
      2. Glass
      3. Metals
    4. Veterinary Injectable Devices Market, By End User , 2021-2031 (USD Million)
      1. Veterinary Hospitals
      2. Veterinary Clinics
      3. Animal Research Institutes
    5. Veterinary Injectable Devices Market, By Geography, 2021-2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
      5. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
  6. Competitive Landscape
    1. Company Profiles
      1. Ceva Santé Animale
      2. Virbac
      3. Dechra Pharmaceuticals PLC
      4. Vetoquinol S.A.
      5. IDEXX Laboratories, Inc.
  7. Analyst Views
  8. Future Outlook of the Market
Download Free Sample NowDownload Free Sample Now